Upgrade to SI Premium - Free Trial

Amgen (AMGN) Reiterated at Neutral by Cantor Fitzgerald

October 5, 2026 7:43 AM
(Updated - October 5, 2026 10:05 AM EDT)

Cantor Fitzgerald analyst Carter Gould reiterated a Neutral rating and $400.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments